EZH2 gene

Last updated on: 20.10.2021

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

EZH2, also called Enhancer Of Zeste 2 Polycomb Repressive Complex 2 Subunit, is a protein coding gene.

Clinical pictureThis section has been translated automatically.

Diseases associated with EZH2 include Weaver syndrome and lymphomas. Furthermore, inactivating mutations in the EZH2 gene are associated with myelodysplastic syndromes. They are considered to be prognostically unfavorable (Ernst T et al. 2010). Related pathways include Activated PKN1 stimulates transcription of AR (androgen receptor)-regulated genes KLK2 and KLK3 and Cellular senescence (REACTOME). An important paralog of this gene is EZH1.

Compared to EZH1-containing complexes, EZH2 is more abundant in embryonic stem cells. The encoded protein plays an important role in the formation of H3K27me3, which is required for embryonic stem cell identity and proper differentiation. The PRC2/EED-EZH2 complex may also serve as a recruitment platform for DNA methyltransferases, linking two epigenetic repression systems. EZH2 can also methylate non-histone proteins such as the transcription factor GATA4 and the nuclear receptor RORA.

LiteratureThis section has been translated automatically.

  1. Ernst T et al (2010) Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders. Nat Genet 42:722-726.
  2. Xiao G et al (2019) EZH2 negatively regulates PD-L1 expression in hepatocellular carcinoma. J Immunother Cancer 7:300.

Last updated on: 20.10.2021